Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Request a Protocol
Ask a
question
Favorite
ChAdOx1 Zika (also known as ChAdOx1 Zika prME ΔTM) was produced as previously described (35) and used as the off-target control vaccine in our challenge experiments. The MAYV-IRES vaccine were previously developed (36), by inserting an IRES in the genome of MAYV and passaging, respectively. Unrelated ChAdOx1 dengue NS1 (unpublished) was used as the mock vaccine in the immunogenicity studies.
Copyright and License information: ©2020 Kroon Campos, Preciado-Llanes, Azar, Kim, Brandon, López-Camacho, Reyes-Sandoval and Rossi
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
